Goodwin advised Korro Bio on the deal.Korro Bio, Inc. announced its $116 million Series B financing. Korro is an RNA editing company focused on discovery and…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
